Autor: Jorge L. Alió

Dr. Mark Babizhayev is a bio-physicist and holds a Ph D  in Biophysics and Pathophysiology from the Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia. He has dedicated many years to scientific research and has written more than 102 published articles and has fifteen patents to his name. The recipient of numerous awards, Dr. Babizhayev is currently Executive Director of Innovative Vision Products, Inc., Delaware, USA, Senior Research Investigator at Moscow Helmholtz Research Institute of Eye Diseases, and Scientific Consultant at EXSYMOL SAM, Monte Carlo, Monaco, and Bruschettini  SRL, Genoa, Italy. He is also one of the principal researchers involved in the development of a breakthrough for the treatment and prevention of senile cataract. Dr. David Wan-Cheng Li is an Associate Professor of Ophthalmology and Visual Sciences in the Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha,  an elected Lotus Scholar Professor of Cell and Developmental Biology of China”s Hunan Normal University by Hunan Province Government, and a Visiting Professor of Ophthalmology and Visual Sciences in the State Key Laboratory in the Zhongshan Ophthalmic Center of Sun Yat-Sen University Medical Center, Guangzhou,  China. He received his Ph D from University of Washington, Seattle, USA, and completed his postdoctoral training at Columbia University, New York, USA. His scientific contributions include the major discoveries that stress-induced apoptosis acts as a common cellular mechanism for non-congenital cataract formation, that human h TERT is compatible with the RNA template from bovine and rabbit, and that different SUMOs have distinct functions in regulating cell differentiation.  He received the outstanding cataract research award from National Foundation for Eye Research and the Lotus Scholar Contribution Award from Hunan Province Government.  He is currently the Editor-in-Chief for Current Molecular Medicine. Dr. Anne Kasus-Jacobi is Assistant Professor of Pharmaceutical Sciences and adjunct faculty in the Departments of Neuroscience and Physiology at the University of Oklahoma Health Sciences Center, Oklahoma City,  USA. She was previously Assistant Professor of Ophthalmology at the Dean Mc Gee Eye Institute in the University of Oklahoma Health Sciences Center. She received her Ph D in Endocrinology from the University of Paris, France, and continued her postdoctoral training in the laboratory of Drs. Michael Brown and Joseph Goldstein at the University of Texas Southwestern Medical Center, Dallas, USA. Dr. Kasus-Jacobi’s current interests include the development of innovative peptide treatments for corneal wounds and antibiotic-resistant bacterial infections. She is a member of the Association for Research in Vision and Ophthalmology and serves as an editorial board member of the Journal of Ocular Diseases and Therapeutics. Dr. Lepša Žorić works in clinical ophthalmology onthe Faculty of Medicine of University of Pristina, Serbia. She completed her Ph D at the University of Pristina with a thesis on anti-oxidation status in aqueous humour, lens and serum of patients with age-related cataracts. A member of several international and national medical and neuro-ophthalmology societies, Dr. Zoric has presented or published more than 100 articles in both domestic and international journals. Dr. Jorge L. Alió is Professor and Chairman of Ophthalmology at the Miguel Hernández University, Alicante, Spain, and formerly chairman of Ophthalmology at the University of Alicante, Spain. He has been appointed with several visiting professorships at universities in the United States and Europe. He attended the Complutense University of Madrid, Spain, where he received a medical degree and a Ph D in biological thermodynamics and its application in the study of ophthalmic pathology. Recipient of the 2012 Lifetime Achievement Award from the International Society of  Refractive Surgery, Dr. Alió’s main research interests include refractive, lens and corneal surgery, ocular inflammation and preventative ophthalmology. His main contributions have been in the area of excimer laser refractive surgery, microincisional lens surgery, and multifocal accommodative and premium IOLs.